Tue. 18 Jun 2024, 3:58pm ET
Benzinga
Biotech, News, General
RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"
Company Profile